NCT02628275View on ClinicalTrials.gov

Impact of Mild or Moderate Physical Activity and Progression of Subclinical Atherosclerosis

NACompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Atherosclerosis
Interventions
BEHAVIORAL

Moderate to vigorous physical activity

55-90% maximum heart rate for 150min/week (current recommendations)

BEHAVIORAL

Light physical activity

40-55% maximum heart rate for 150min/week

Trial Locations (1)

G1V 4G5

Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Québec

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Laval University

OTHER

NCT02628275 - Impact of Mild or Moderate Physical Activity and Progression of Subclinical Atherosclerosis | Biotech Hunter | Biotech Hunter